NASDAQ:TRVI | EBITDA | Trevi Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2022-03-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$14.88M
2025-12-31-$10.19M
2025-03-31-$11.43M
2024-12-31-$12.21M
2024-03-31-$11.87M
2023-12-31-$8.9M
2023-03-31-$7.54M
2022-12-31-$6.64M
2022-03-31-$7.01M

Annual EBITDA

DateEBITDA
2025-12-31-$49.18M
2024-12-31-$51.38M
2023-12-31-$33.8M
2022-12-31-$29.86M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.